Introduction
Organ transplant recipients (OTRs) have a well-known increased risk of developing cancer due to immunosuppression [1] . Nonmelanoma skin cancer, particularly cutaneous squamous cell carcinoma (cSCC), is the most common malignancy seen in OTRs. Compared with the general population, the risk of developing cSCC is 60 to 100 times greater in OTRs [2] [3] [4] . Furthermore, cSCCs in OTRs have been shown to be more numerous and more aggressive compared with cSCCs in immunocompetent individuals [5] [6] [7] . In addition, the incidence of cSCC is proportional to the level of immunosuppression and is often associated with human papillomavirus (HPV) infection [8] . The pathogenesis of cSCC is multifactorial. For both OTRs and immunocompetent individuals, the most important risk factor for development of cSCC is UV radiation [9] . Fair skin is also seen as a risk factor [10] . There is a strong correlation between age and cSCC, with the highest incidence rates observed in men and women over 85 years of age [11] . Another risk factor for cSCC is the presence of oncogenic viruses in the skin [12] . In recent years, HPV has been associated with cSCC in OTRs. Among these patients, 80% of cSCCs are associated with HPV infection, in contrast to only 40% among immunocompetent individuals [13] . Greater age at transplantation as well as higher doses and longer duration of immunosuppressive regimens have also been identified as risk factors [9, 14] .
Histopathologically, cSCC originates from epidermal keratinocytes and consists of nests, sheets, and strands of epithelial cells that arise from the epidermis and invade into the dermis for a variable distance. The cSCCs are commonly divided into 3 categories: well differentiated, moderately differentiated, and poorly differentiated depending on the resemblance of the tissue of origin. There are no clear objective parameters for grading the differentiation of cSCCs [15] , but one classification is that >75% of the cells are differentiated in well-differentiated tumors, 25%-75% in moderately differentiated tumors, and <25% in poorly differentiated tumors [7] . Well-differentiated cSCCs tend to grow at a slower rate and metastasize to a lesser extent than tumors that are poorly differentiated [16] .
Results: During 2002 During -2015 OTRs diagnosed with 515 tumors and 883 non-OTRs with 1,247 tumors were included. OTRs developed 0.47 tumors/year vs 0.10 tumors/year for non-OTRs, but no significant differences were observed in the degree of tumor differentiation of invasive cSCCs between OTRs and non-OTRs (P = 0.4). The distribution of poorly, moderately, and well-differentiated invasive cSCCs among OTRs and non-OTRs were 8.5% vs 12.5%, 22.1% vs 29.9%, and 69.4% vs 57.6%, respectively.
Conclusions:
OTRs do not develop a higher proportion of poorly differentiated cSCCs than nonOTRs. 
ABSTRACT

cSCC and cSCC In Situ
The tumor characteristics for both groups are presented in Table 2 with available data while also stratifying with respect to age group between the OTRs and non-OTRs, no significant difference was seen (P value 0.4, Mantel-Haenszel test).
As an incidental finding, an association was seen between the distribution of the level of differentiation of cSCCs and age groups below and above the median age at diagnosis in both groups. OTRs who were above the median age of 62 years had significantly fewer well-differentiated cSCCs (61%, CI 52-70) than younger OTRs (76%, CI 69-83) cSCC, moderately differentiated cSCC, poorly differentiated cSCC, and "cSCC, other" (including cases of invasive or microinvasive cSCC without a specified degree of differentiation, cSCC and basosquamous carcinoma). In some cases, the same tumor had several histopathological reports, eg, the first report was from a punch biopsy and the second report from when the tumor was excised in toto. In such cases, the lowest differentiation level was chosen, and the same tumor is represented only once in the material.
Statistical Analysis
All data were analyzed using R version 3.0.3 (The R Foundation for Statistical Computing, Vienna, Austria) and Stata version 13.1 (STATA Corporation, College Station, TX).
The Fisher exact test was used to compare proportions.
The Mantel-Haenszel test was used to compare proportions across groups stratifying with respect to age group (<55 years, 55-64 years, and ≥65 years). The Wilcoxon rank sum test was used for 2-sample tests. All tests are 2-sided. P values <0.05 and 95% confidence intervals (CI) were considered statistically significant.
Relative survival was computed using the Ederer II method [18] . Mortality data for the general population in Sweden were used to estimate expected survival rates for the study populations. The mortality data contained the probability of death for single-year age groups and gender 
Results
Analysis of Study Population
Patient characteristics are shown in Table 1 . A total of 82 OTRs were included, of which 36 (44%) were women and 46 (56%) were men. The mean and median ages at non-OTRs 60%, P < 0.0001) and cSCC in situ (OTRs 28%
and non-OTRs 49%, P = 0.001). There was no significant difference in the degree of differentiation for cSCCs in the head and neck area when comparing OTRs and non-OTRs.
However, cSCCs in the head and neck area showed significantly poorer tumor differentiation compared with cSCCs on other body sites, when stratifying with respect to age groups (P < 0.00001).
Survival Analysis
The relative survival showed no difference between the 2 groups ( Figure 2 ). For non-OTRs, the relative survival was 0.84 (CI 0.78-0.89) and for OTRs it was 0.78 (CI 0.65-0.88).
Discussion
The correlation between immunosuppression and skin cancer has been extensively studied [1, 3, 4] ing no significant differences in smaller series [19, 20] .
There are several studies that show a more lethal and more aggressive behavior of cSCCs in OTRs [7, 21] . However, 
Tumor Site
Another incidental finding was the distribution of the anatomic location of the tumors in the 2 groups. The tumor site differed significantly between the OTR and the non-OTR groups when stratifying for age group (P < 0.0001, MantelHaenszel test). OTRs had a significantly larger proportion of tumors on the upper extremities (27% vs 10%, P < 0.0001) and the trunk (22% vs 16%, P = 0.003). In contrast, the non-OTRs had a significantly higher proportion of tumors in the head and neck area (59% vs 34%, P < 0.0001). When comparing the anatomic location of the tumors between the OTR and non-OTR groups for invasive cSCCs and cSCC in situ lesions separately, the significant difference remained (P < 0.0001 for invasive cSCCs and P = 0.003 for the in situ lesions). When comparing the proportion of lesions on the head and neck between OTRs and non-OTRs, the significant difference also remained for invasive cSCCs (OTRs 38% and infection, in contrast to only 40% among immunocompetent individuals [13] .
With regard to the relative survival, no significant difference was seen between OTRs and non-OTRs, but the comparison is difficult to make due to the large difference in mean age between the groups.
A strength of this study is that the conditions for population studies in Sweden are ideal, thanks to a history of extensive record-keeping and the fact that each citizen is assigned a unique social security number at birth, allowing all citizens to be traced through different records over time across the whole country without missing data, except if patients emigrate. There are, however, some limitations as well. Among both OTRs and non-OTRs, 11% of the invasive cSCCs had an unknown degree of differentiation. We were also confined to the use of the electronic chart system, which was implemented at SUH in 2002. Since there is no national central medical record, we were not able to follow up with patients who may have been diagnosed with cSCC at other clinics. Finally, other factors that may also contribute to the aggressiveness of cSCCs (eg, tumor depth) were not analyzed.
Conclusions
There was no significant difference between the groups with regard to the proportion of poorly differentiated cSCCs. cSCCs (68.3%) [22] . In comparison with the non-OTRs, there was no significant difference in the degree of tumor differentiation. In fact, there was a slightly higher proportion of poorly differentiated cSCCs among non-OTRs (not significant).
As an incidental finding, we discovered that there was a higher frequency of poorly differentiated cSCCs in the to closer follow-up visits may also play a role among OTRs [23] . Notably, cSCC in situ was significantly more common in
OTRs. This has also been seen in other studies [2, 24] . NMSCs per person-year was 0.30 [2] . The higher number of tumors per person-year in our study may be explained by the fact that the study period was more recent and the incidence of cSCC in Sweden has increased during the past decade [25] . The patients in our study had also been immunosuppressed for a longer period of time (13.5 years vs 9.2 years).
Furthermore, the knowledge about the risk of cSCC in OTRs has increased and nowadays there is a much more organized system for follow-up visits which might have resulted in more diagnosed cases per patient.
Surprisingly, non-OTRs had a significantly higher proportion of tumors in the head and neck area compared with OTRs and the significance remained when comparing the anatomic location of the tumors between the groups for cSCCs and cSCC in situ lesions separately. All patients who undergo transplantation at SUH receive information about the risks of sun exposure. A hypothesis may be that OTRs therefore use sunscreen on the chronically exposed facial skin more frequently than non-OTRs. Another explanation could be that UV radiation is not the only risk factor for cSCCs in OTRs. In OTRs, 80% of cSCCs are associated with HPV
